You Canceled The Infusion.
If your doctor moved you past the first-line bone pills and prescribed Reclast, and you decided you were not spending three days a year in bed with what the label calls an acute-phase reaction, this page is written for you. It will explain what your standard supplement stack has been missing and why your scan has still been declining.
- Your diagnosis was severe enough that your doctor did not offer daily pills. She reached for Reclast. That was the sentence in that appointment that changed everything.
- You read the prescribing information. Fifteen minute IV infusion at a clinic. Once a year. Fever, muscle pain, and headache lasting up to three days after each infusion in a documented percentage of first-time patients. Kidney function monitoring required before every visit. You decided you were not spending three days of every year in bed with what the label calls an acute-phase reaction.
- You have been on calcium, D3, and K2 ever since. Every morning without fail. And your next scan is still coming, and quietly you have started calculating how many good years you have left before the fall that changes everything.
- You looked at your mother's posture at the last family gathering and you felt sick with recognition. That is not what you want your daughter to see when she looks at you in ten years.
You canceled Reclast because you wanted to stay in a relationship with your body where you did not lose three days of every year to a drug that was supposed to protect you. Every scan that has come back worse since then has felt like your body was punishing you for that choice.
It is not. Your body has been doing the job the whole time. The supplement stack you have been giving it has been running at three of four steps of a four-step relay it needs to rebuild.
This is Marlene Ashworth's story, and it is written for anyone whose doctor tried to escalate her to the yearly IV infusion.
Marlene was 61 when her endocrinologist told her that the daily pills were not going to be enough. Her T-score had moved into severe osteoporosis territory. The doctor pulled up Reclast on her screen.
Fifteen minute IV infusion at the clinic. Once a year. Kidney function bloodwork required before every visit. FDA-documented acute-phase reaction affecting a significant percentage of first-time patients. Fever, muscle pain, and headache for one to three days after the infusion. Marlene read the printout twice at her kitchen table. Then she folded it in half and put it in the recycling bin.
She did what most women in her position do next. Calcium every morning without fail. D3 after her doctor mentioned it. K2 after a Facebook group told her it was the final piece. Eight months later her follow-up scan came back worse.
On the drive home she remembers thinking that nothing helped, maybe slowed it at best. It was devastating to hear the number a second time. Her doctor's office called about scheduling the Reclast infusion twice. Marlene canceled both times.
She was doing it right. She was doing it every day. The trend line was gradually getting worse anyway.
"I kept that scan in my car for six days before I could bring myself to show my husband. I was not spending three days in bed with fever and body aches every year for as long as they said. I was not doing that. But three years in I was scared every day that canceling had been the wrong call. Nobody could tell me what I was doing wrong."Marlene Ashworth, 62. Retired librarian, Cincinnati.
Here is what nobody in any appointment ever told her. And it is the piece that changes the whole conversation you have been having with yourself since you refused the injection.
Bone absorption runs on a four-step chain
Bone is not a container that stores calcium. It is living tissue that breaks down and rebuilds on a monthly cycle. The minerals doing the rebuilding have to arrive at the correct location, in the right form, at the right time.
Four minerals are required. Each has a specific job. And each depends on the step before it to function.
Every mainstream bone supplement sold at scale contains calcium and D3. Some add K2. Almost none contain boron at a dose that finishes the chain.
The chain breaks at the final step. Every month. Every scan. That is not a claim without a mechanism. It is a documented pathway with a missing link that the supplement industry never had a financial reason to close.
Boron is not new. It has been in nutritional research since the early 1990s. What is new is a formula that includes it in the correct position alongside the other three steps in one delivery.
Your doctor did not recommend Reclast lightly. It is not a first-line drug. It is prescribed when the oral bisphosphonate route is not considered enough. That means your diagnosis was already in the range where fracture risk is elevated. The recommendation itself is the clock.
Post-menopausal bone loss runs at three to five percent per year in women without estrogen and without a complete co-factor formula 7. That number does not pause while you shop for a different supplement.
Research published in the Journal of Bone and Mineral Research found that women who experience one osteoporosis-related fracture face significantly elevated risk of a second within the following two years 6. The first fracture is not the end of the story. It is the beginning of a different one.
What actually sits on the shelf, side by side
You are not comparing this to nothing. You are comparing it to the yearly infusion you already canceled, to the three-supplement stack that has been failing you, and to the option of continuing exactly what you are doing now.
| Somara Complete Chain |
Reclast (zoledronic acid) |
Standard 3-Stack (Ca + D3 + K2) |
Doing Nothing | |
|---|---|---|---|---|
| All 4 co-factor chain steps | ✓ | N/A | ✗ Missing boron |
✗ |
| Delivery method | Sublingual liquid dropper | ✗ Annual IV infusion at clinic |
Tablets and capsules | N/A |
| FDA-documented warnings | ✓ None reported |
✗ Acute-phase reaction, kidney monitoring, jaw, femur |
✓ None |
✓ None |
| Days per year potentially spent recovering | Zero | ✗ Up to 3 days after each infusion |
Zero | Zero |
| Third-party batch tested | ✓ | N/A | Varies | N/A |
| Monthly cost (typical) | $49 | $110 to $210 $1,300 to $2,500 per annual infusion |
$60 to $120 | $0 |
| Money-back guarantee | 30 days | ✗ | Varies | N/A |
The three-supplement stack most women in this position are already on gives you three of four steps of the chain. That is not a small tolerance. It is the deficit that shows up on the next scan.
What silent bone loss actually takes from you
Bone loss does not stay the same. It compounds. Every month the chain runs at three of four steps, more ground is lost than the month before. And what it takes is not what most women expect.
This is what accumulates while the chain runs at three of four steps. It is not one appointment away. It is compounding right now.
The complete co-factor formula, in one sublingual delivery
There is a reason this combination did not exist on the mainstream supplement shelf before. There is no patent on a mineral. No pharmaceutical company funds research that cannot generate drug revenue. Boron does not have a lobby. No brand had a financial reason to include the step that makes the chain hold together.
The complete co-factor formula puts all four steps of the chain into a single sublingual liquid dropper. Absorbed directly under the tongue in minutes. No infusion. No days of fever afterward. No annual clinic appointment.
It is called the Bone Density Complex.
- STEP 1Vitamin K2 as MK-7Long-half-life form used in three-year clinical studies180 mcg
- STEP 2Vitamin D3From wild-harvested lichen2,000 IU
- STEP 3Magnesium GlycinateThe form the body actually absorbs300 mg
- STEP 4Boron CitrateThe step that finishes the chain5 mg
- BASECalcium from Organic AlgaeMore bioavailable than calcium carbonate500 mg
- SUPPORTZinc, Potassium, Vitamin C from Elderberry, Sea Moss ExtractBlend
One dropper in the morning and one in the evening. That is the complete daily protocol. No IV. No recovery days.
This is not another bottle to add to a stack. It is a replacement for the stack that has been failing. And it is a return to the relationship with your body you were fighting to keep the day you canceled the infusion.
What Marlene noticed. And what you can expect.
Marlene switched to the complete co-factor formula in early 2025. Her stack went from five separate bottles to one dropper twice a day.
"Around month two I realised I had stopped bracing myself getting out of the car. I had been doing it for years without registering it."
"Six months in, I went back for the follow-up scan. My doctor looked at the printout and looked at it again. She said the number had held. Not improved yet. Held. The office did not call to reschedule the Reclast infusion after that appointment. For the first time in three years."
DEXA improvement can take twelve to twenty-four months for most women who stay consistent. The 30-day guarantee is not about the scan. It is about whether the body registers that something has changed. If it has not, you do not pay.
Other women who refused
The decision most women wish they had made sooner
Three years of the standard three-supplement stack averages between two thousand and three thousand dollars for a woman who commits to it consistently.
Three years of a formula that runs at three of four steps of the co-factor chain is three years of scans going in the wrong direction anyway. And with a Reclast-level diagnosis already on the record, three more years is not a small window.
The complete co-factor formula is not more expensive than what most women in this position are already spending on supplements. It is a replacement for the stack that has been failing, not another bottle on top of it.
The 30 days between now and the guarantee window is not a bet. It is a diagnostic. Either the body registers that something has changed or it does not. If it does not, the refund is full and no questions asked.
What you cannot get back are the months between now and the next scan. Those are happening whether the formula in your body works or not.
Your formula was never complete.
And this is the return of the trust you were trying to keep."
Frequently asked questions
References
- Knapen MH et al. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International.
- Vermeer C (2012). Vitamin K: the effect on health beyond coagulation. Molecular Nutrition and Food Research.
- Uwitonze AM & Razzaque MS (2018). Role of magnesium in vitamin D activation and function. Journal of the American Osteopathic Association.
- Nielsen FH (2004). Update on human health effects of boron. Journal of Trace Elements in Experimental Medicine.
- Newnham RE (1994). Essentiality of boron for healthy bones and joints. Environmental Health Perspectives.
- Kanis JA et al. Osteoporosis-related fracture recurrence risk. Journal of Bone and Mineral Research.
- Riggs BL & Melton LJ (1986). Involutional osteoporosis. New England Journal of Medicine. Post-menopausal bone loss rate 3-5% per year in early post-menopause.
- Novartis Pharmaceuticals. Reclast (zoledronic acid) prescribing information. FDA-required warnings including acute-phase reaction, renal impairment, and osteonecrosis of the jaw.